发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| USA | 112 |
| Italy | 50 |
| Spain | 38 |
| England | 33 |
| Canada | 22 |
| GERMANY (FED REP GER) | 19 |
| South Korea | 18 |
| Australia | 15 |
| Greece | 14 |
| Japan | 14 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| HARVARD UNIVERSITY | 15 |
| UNIVERSITY OF LONDON | 12 |
| CIBER - CENTRO DE INVESTIGACION BIOMEDICA EN R... | 11 |
| MAYO CLINIC | 11 |
| HARVARD PILGRIM HEALTH CARE | 10 |
| STATE UNIVERSITY SYSTEM OF FLORIDA | 10 |
| DUKE UNIVERSITY | 9 |
| SAPIENZA UNIVERSITY ROME | 9 |
| MEDICAL UNIVERSITY OF VIENNA | 8 |
| RUSSIAN ACADEMY OF SCIENCES | 8 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| Ten Years' Experience with the CYP2D6 Activity Score: A ... | 27 |
| The Developing Story of Predictive Biomarkers in Colorec... | 26 |
| Multiple Exon Skipping in the Duchenne Muscular Dystroph... | 16 |
| Pharmacogenomics of Novel Direct Oral Anticoagulants: Ne... | 16 |
| Physician-Reported Benefits and Barriers to Clinical Imp... | 15 |
| The Role of Next-Generation Sequencing in Precision Medi... | 15 |
| Restoring Dystrophin Expression in Duchenne Muscular Dys... | 15 |
| Pharmacogenomic Impact of CYP2C19 Variation on Clopidogr... | 14 |
| Pharmacogenomics of CYP2C9: Functional and Clinical Cons... | 12 |
| Feasibility of a Comprehensive Home Monitoring Program f... | 10 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| J PERS MED | 19 |
| JMIR MHEALTH UHEALTH | 16 |
| INT J ENV RES PUB HE | 10 |
| INT J MOL SCI | 10 |
| GENET MED | 9 |
| PHARMACOGENOMICS | 9 |
| PHARMACOGEN PERS MED | 7 |
| J MED INTERNET RES | 6 |
| PERS MED | 6 |
| BRIT J CLIN PHARMACO | 5 |